A RETROSPECTIVE COHORT ANALYSIS OF ANTIRETROVIRAL TREATMENT MODIFICATIONS
... implies that such data are not an accurate reflection of what actually happens in routine care, especially in the developing world. Reports from clinical trials which aim to measure efficacy are different to those that follow routine programme cohorts. In clinical trials, typically, it is reported t ...
... implies that such data are not an accurate reflection of what actually happens in routine care, especially in the developing world. Reports from clinical trials which aim to measure efficacy are different to those that follow routine programme cohorts. In clinical trials, typically, it is reported t ...
Save a Life Neuro-Optometry Primer
... be to incorporate a neurological screening into my optometric practice. That effort gave rise to this primer, developed to encourage more optometrists to add aspects of neuro-optometry into their practices. This primer is intended to accomplish the following: ● Review the basics of neuroanatomy ● De ...
... be to incorporate a neurological screening into my optometric practice. That effort gave rise to this primer, developed to encourage more optometrists to add aspects of neuro-optometry into their practices. This primer is intended to accomplish the following: ● Review the basics of neuroanatomy ● De ...
Ciguatera - UNC School of Medicine
... Other Drugs used to treat Ciguatera Poisoning Initial treatment of ciguatera is supportive. Multiple uncontrolled trials have found that intravenous mannitol, given at a dose of 1 g/kg, reduces neurologic symptoms when given within the first 48 hours. See Abstract for Palafox, NA, Jain, LG, Pinano, ...
... Other Drugs used to treat Ciguatera Poisoning Initial treatment of ciguatera is supportive. Multiple uncontrolled trials have found that intravenous mannitol, given at a dose of 1 g/kg, reduces neurologic symptoms when given within the first 48 hours. See Abstract for Palafox, NA, Jain, LG, Pinano, ...
Nutropin Prescribing Information
... There have been reports of fatalities after initiating therapy with somatropin in pediatric patients with PWS who had one or more of the following risk factors: severe obesity, history of upper airway obstruction or sleep apnea, or unidentified ...
... There have been reports of fatalities after initiating therapy with somatropin in pediatric patients with PWS who had one or more of the following risk factors: severe obesity, history of upper airway obstruction or sleep apnea, or unidentified ...
Female Urology - American Urological Association
... signs that characterize OAB and exclude other disorders that could be the cause of the patient’s symptoms; the minimum requirements for this process are a careful history, physical exam, and urinalysis. Clinical Principle • In some patients, additional procedures and measures may be necessary to val ...
... signs that characterize OAB and exclude other disorders that could be the cause of the patient’s symptoms; the minimum requirements for this process are a careful history, physical exam, and urinalysis. Clinical Principle • In some patients, additional procedures and measures may be necessary to val ...
Prescribing Information for SPIRIVA HandiHaler
... had COPD with a mean pre-bronchodilator forced expiratory volume in one second (FEV1) percent predicted of 39% to 43%. Patients with narrow-angle glaucoma, or symptomatic prostatic hypertrophy or bladder outlet obstruction were excluded from these trials. An additional 6-month trial conducted in a V ...
... had COPD with a mean pre-bronchodilator forced expiratory volume in one second (FEV1) percent predicted of 39% to 43%. Patients with narrow-angle glaucoma, or symptomatic prostatic hypertrophy or bladder outlet obstruction were excluded from these trials. An additional 6-month trial conducted in a V ...
Empiric Combination Therapy for Gram-Negative
... appropriate for renal function. Similarly, all b-lactam dosing followed the recommended dosing in the JHH “Guidelines for the Management of Bloodstream Infections in Neonatal and Pediatric Patients.”19 Of note, no patients received prolonged infusion b- lactam therapy or extended-interval aminoglyco ...
... appropriate for renal function. Similarly, all b-lactam dosing followed the recommended dosing in the JHH “Guidelines for the Management of Bloodstream Infections in Neonatal and Pediatric Patients.”19 Of note, no patients received prolonged infusion b- lactam therapy or extended-interval aminoglyco ...
Immune Globulin Replacement Therapy
... ITP (chronic), when the platelet count is dangerously low, defined as a platelet count less than 30,000 cells/mm3 in children, less than 20,000 cells/mm3 in adults, or less than 30,000 cells/mm3 along with signs/symptoms of bleeding in adults. ITP in pregnancy, when at least one of the following cri ...
... ITP (chronic), when the platelet count is dangerously low, defined as a platelet count less than 30,000 cells/mm3 in children, less than 20,000 cells/mm3 in adults, or less than 30,000 cells/mm3 along with signs/symptoms of bleeding in adults. ITP in pregnancy, when at least one of the following cri ...
Mesalamine rectal Suppositories (Canasa) Tumor Necrosis Factor
... a. Pregnant or breastfeeding b. Multiple sclerosis c. Active malignance d. Severe CHF 5. Have appropriate labs been completed to demonstrate member does not have latent or active tuberculosis or is a carrier of Hepatitis B virus? 6. Does the member have a diagnosis of severe fistulizing Crohn’s dise ...
... a. Pregnant or breastfeeding b. Multiple sclerosis c. Active malignance d. Severe CHF 5. Have appropriate labs been completed to demonstrate member does not have latent or active tuberculosis or is a carrier of Hepatitis B virus? 6. Does the member have a diagnosis of severe fistulizing Crohn’s dise ...
Hepatitis C and injecting drug use an overview.
... The number of adults that had ever injected receiving drug treatment has increased by a third (from 84,216, 2005/06 to 111,939, 2011/12). The vast majority of PWID asked report recent use of a needle & syringe programme (NSP) (83% in 2012, UAM Survey). NSP coverage needs to be improved in England as ...
... The number of adults that had ever injected receiving drug treatment has increased by a third (from 84,216, 2005/06 to 111,939, 2011/12). The vast majority of PWID asked report recent use of a needle & syringe programme (NSP) (83% in 2012, UAM Survey). NSP coverage needs to be improved in England as ...
TRAMADEX®
... Many of the tramadol-related deaths have occurred in patients with previous histories of emotional disturbances or suicidal ideation or attempts as well as histories of misuse of tranquilizers, alcohol, and other CNS-active drugs. Some deaths have occurred as a consequence of the accidental ingestio ...
... Many of the tramadol-related deaths have occurred in patients with previous histories of emotional disturbances or suicidal ideation or attempts as well as histories of misuse of tranquilizers, alcohol, and other CNS-active drugs. Some deaths have occurred as a consequence of the accidental ingestio ...
- Gastroenterology
... joint count, physician’s assessment of disease activity, and patient’s assessment of physical function and levels of acute phase reactant) and the mean change from baseline in the modified total Sharp score of joint radiographs at week 54.12 The major secondary end point was a PRO: the Disability Ind ...
... joint count, physician’s assessment of disease activity, and patient’s assessment of physical function and levels of acute phase reactant) and the mean change from baseline in the modified total Sharp score of joint radiographs at week 54.12 The major secondary end point was a PRO: the Disability Ind ...
A Pilot Study of Maudsley Family Therapy With Group Dialectical
... diagnoses, day treatment options have become popular and cost-effective strategies for treating patients in crisis because they provide more structure and support than outpatient intervention but significantly less restriction than inpatient settings (Neuhaus, 2006). Thus, these types of programs ca ...
... diagnoses, day treatment options have become popular and cost-effective strategies for treating patients in crisis because they provide more structure and support than outpatient intervention but significantly less restriction than inpatient settings (Neuhaus, 2006). Thus, these types of programs ca ...
Sex-based differences in autoimmune diseases
... various environmental factors in genetically predisposed individuals. RA is about three times more common in women than in men, with a peak age of onset in the fifth decade of life. The female to male prevalence ratio is around 2:1 in 55 to 64-year-olds, shifting to a male excess in people over 75-y ...
... various environmental factors in genetically predisposed individuals. RA is about three times more common in women than in men, with a peak age of onset in the fifth decade of life. The female to male prevalence ratio is around 2:1 in 55 to 64-year-olds, shifting to a male excess in people over 75-y ...
Sacubitril/valsartan for chronic heart failure: its
... in sacubitril/valsartan in the USA, Novartis has announced a new programme of clinical trials, some of which are already under way. FortiHFy will include 40 trials, generating data on “symptom reduction, efficacy, safety, quality of life benefits and real world evidence” in heart failure.16 Most o ...
... in sacubitril/valsartan in the USA, Novartis has announced a new programme of clinical trials, some of which are already under way. FortiHFy will include 40 trials, generating data on “symptom reduction, efficacy, safety, quality of life benefits and real world evidence” in heart failure.16 Most o ...
Rheumatoid Arthritis
... and shoulders. In most cases symptoms occur in the same joints on both ides of the body. ...
... and shoulders. In most cases symptoms occur in the same joints on both ides of the body. ...
Introduction - Orl-nko
... 4.3.2.3. Excessive visual dependance (*) (generally after vestibular deficiency) 4.3.2.4. Post refraction change Multifocal lenses Important and recent refraction correction ...
... 4.3.2.3. Excessive visual dependance (*) (generally after vestibular deficiency) 4.3.2.4. Post refraction change Multifocal lenses Important and recent refraction correction ...
Prescribing Information
... The dosage, frequency, and number of injection sites should be tailored to the individual patient based on the size, number, and location of muscles to be treated, severity of spasticity, presence of local muscle weakness, patient’s response to previous treatment, and adverse event history with XEOM ...
... The dosage, frequency, and number of injection sites should be tailored to the individual patient based on the size, number, and location of muscles to be treated, severity of spasticity, presence of local muscle weakness, patient’s response to previous treatment, and adverse event history with XEOM ...
Parkinson`s - Innovative Educational Services
... word “disease,” and for other reasons, the phrase Parkinson’s Syndrome (PS) is now being used by some groups instead of the phrase Parkinson’s Disease. When Parkinsonism symptoms occur as a secondary symptom of some brain disorder other than Parkinson’s Disease (such as Alzheimer’s Disease), this is ...
... word “disease,” and for other reasons, the phrase Parkinson’s Syndrome (PS) is now being used by some groups instead of the phrase Parkinson’s Disease. When Parkinsonism symptoms occur as a secondary symptom of some brain disorder other than Parkinson’s Disease (such as Alzheimer’s Disease), this is ...
Merck KGaA, Darmstadt, Germany, and Pfizer
... indication for avelumab in combination with, and as follow-on treatment to, platinum-based chemotherapy in patients with previously untreated epithelial ovarian cancer, Pfizer’s and Merck KGaA, Darmstadt, Germany’s immuno-oncology alliance involving anti-PD-L1 and anti-PD-1 therapies, and clinical d ...
... indication for avelumab in combination with, and as follow-on treatment to, platinum-based chemotherapy in patients with previously untreated epithelial ovarian cancer, Pfizer’s and Merck KGaA, Darmstadt, Germany’s immuno-oncology alliance involving anti-PD-L1 and anti-PD-1 therapies, and clinical d ...
Twenty-Five Years of Progress Against Hepatitis C
... the FDA approved the combination of interferon and ribavirin for use in hepatitis C patients, bringing cure rates to 29% for genotype 1 patients.27 In 2001, pegylated interferon, a chemically modified version of interferon designed to persist longer in the patient’s body was approved. Later that yea ...
... the FDA approved the combination of interferon and ribavirin for use in hepatitis C patients, bringing cure rates to 29% for genotype 1 patients.27 In 2001, pegylated interferon, a chemically modified version of interferon designed to persist longer in the patient’s body was approved. Later that yea ...
Epidemiology and MRI
... Título / Title: Magnetic Resonance Imaging evaluation of brain volume and clinical parameters in Multiple Sclerosis patients Introdução / Introduction: There is an increasing amount of evidence suggesting the correlation between brain volume loss and physical disability in Multiple Sclerosis (MS) pa ...
... Título / Title: Magnetic Resonance Imaging evaluation of brain volume and clinical parameters in Multiple Sclerosis patients Introdução / Introduction: There is an increasing amount of evidence suggesting the correlation between brain volume loss and physical disability in Multiple Sclerosis (MS) pa ...
![[Product Monograph Template - Schedule D]](http://s1.studyres.com/store/data/012846683_1-204aeb8c34ebd7ce9143aea97ba6f3e4-300x300.png)
[Product Monograph Template - Schedule D]
... Rarely, human normal immunoglobulin can induce a fall in blood pressure with anaphylactic reaction, even in patients who had tolerated previous treatment with human normal immunoglobulin. In case of hypersensitivity, discontinue the Hizentra infusion immediately and institute appropriate treatment. ...
... Rarely, human normal immunoglobulin can induce a fall in blood pressure with anaphylactic reaction, even in patients who had tolerated previous treatment with human normal immunoglobulin. In case of hypersensitivity, discontinue the Hizentra infusion immediately and institute appropriate treatment. ...
Project Title
... sometimes leading to a fully developed Cushing’s syndrome. If administration is discontinued these symptoms are usually reversed, but sudden cessation is dangerous. Rapid intravenous administration of large doses of corticosteroids may cause cardiovascular collapse. Other adverse effect include amen ...
... sometimes leading to a fully developed Cushing’s syndrome. If administration is discontinued these symptoms are usually reversed, but sudden cessation is dangerous. Rapid intravenous administration of large doses of corticosteroids may cause cardiovascular collapse. Other adverse effect include amen ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.